Xcellderma™ (NDC 84076-111-01) is a FDA cleared, over the counter (OTC) sterile wound cream and is effective for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds. During the last several years, a scientific and medical consensus has emerged that elevated protease levels impede wound healing. QBx™ technology, the active ingredient, down regulates the production of certain proteases and matrix metalloproteases, or MMPs, which are protein enzymes that are proven to impede the healing of a majority of chronic wounds. Approximately 80% of chronic wounds display elevated levels of proteases (including MMPs).
Regenerex Pharma, Inc. was incorporated in 2021. Regenerex has corporate offices located in Gordansville, Tennessee and a manufacturing facility in Memphis, Tennessee.